Xeris Biopharma Holdings Shares Jump 14% on Raised 2023 Outlook

By Denny Jacob Xeris Biopharma Holdings shares jumped 14%, to $2.56, after the biopharmaceutical company raised part of its outlook for 2023. The stock has...

Related Keywords

Denny Jacob ,Paul Edick ,Xeris Biopharma Holdings ,Biopharma Holdings ,Chief Executive Paul ,Article Normal ,Biotechnology Services ,Pharmaceuticals ,Healthcare Life Sciences ,Biopharmaceuticals ,Financial Performance ,Share Price Movement Disruptions ,Corporate Industrial News ,Content Types ,Factiva Filters ,C Amp Ampe Exclusion Filter ,C Amp Ampe Industry News Filter ,Synd ,Sixers ,Us98422e1038 ,Share Price Movement ,Disruptions ,Corporate ,Industrial News ,Healthcare ,Life Sciences ,